查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
美国生物製药第三方物流市场规模、份额和趋势分析报告：按供应链（冷链、非冷链）、服务、产品类型（专业製药）、细分市场预测，2022-2030 年
市场调查报告书
商品编码
1170868

美国生物製药第三方物流市场规模、份额和趋势分析报告：按供应链（冷链、非冷链）、服务、产品类型（专业製药）、细分市场预测，2022-2030 年

U.S. Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Product Type (Specialty Drug), And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 78 Pages | 商品交期: 2-10个工作天内

价格

美国生物医药第三方物流市场的发展与趋势

根据 Grand View Research, Inc. 的最新报告，美国生物製药第三方物流市场规模预计到 2030 年将达到 872 亿美元，预测期内復合年增长率为 7.3%。 对新型生物製剂不断增长的需求和管理它们的需求正在推动市场增长。 推动增长的其他因素包括对跨不同地区运输生物製品的温控物流服务的需求不断增加，以及分销网络的扩张以促进生物製药公司的销售。

由于航空运输能力下降以及仓库和机场劳动力减少，COVID-19 大流行对全球物流产生了一定程度的重大影响。 物流服务也受到地方政府暂停物流基础设施、实施行动限制和製定额外要求以遏制病毒传播的决定的影响。 结果，许多供应业务受到很大阻碍。

随着与运输和就地避难义务相关的政府法规的消退，美国生物製药第三方物流行业的未来可能是有利的。 大流行期间观察到对冷链物流的需求激增。 到 2021 年，我们预计 COVID-19 疫苗的生产和分销将会增长。 例如，2021 年 3 月，联邦快递开始为 McKesson Corp. 向美国各地的中心运送 COVID-19 疫苗，自 2020 年 12 月中旬以来，该公司已经运送了数百万支 COVID-19 疫苗。我在这里。

美国生物医药第三方物流市场亮点

非冷链物流占比最大，为80.2%，因为销售的医药产品很多不需要温控。

在对细胞疗法、疫苗和检测试剂盒等生物製剂需求的推动下，冷链物流行业预计在预测期内实现 10.1% 的最快复合年增长率。

对 COVID-19 疫苗不断增长的需求是市场增长的主要驱动力。 此外，物流服务外包的增长趋势也推动了增长。

随着仓储需求的增加，仓储业获得最大的市场份额，达到 43.4%

2021 年，由于专科药的强劲增长，专科药以 39.2% 的最大份额占据市场主导地位。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 供应链
    • 服务类型
    • 产品类型
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
    • 批量价格分析（模型 2）
  • 二级信息列表
  • 主要信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望

第三章市场定义

  • 按供应链
  • 按服务类型
  • 产品类型

第 4 章美国生物製药第三方物流市场：变量、趋势和范围

  • 市场细分和范围
  • 市场驱动因素分析
    • 物流技术进步
    • 扩大逆向物流在生物製药行业的应用
    • 对冷链物流的需求不断增长
  • 市场製约因素分析
    • 外包期间的合规问题
  • 描绘渗透率和增长前景
  • 波特的五力分析
  • PESTEL 分析
  • Covid 影响和改革分析

第 5 章有关 Hub 服务、共付额和依从性的定性信息

  • 中心服务
  • 自费
  • 合规

第六章美国生物製药第三方物流市场：供应链环节分析

  • 美国生物製药第三方物流市场：2021 年和 2030 年市场份额分析
  • 冷链物流
  • 非冷链物流

第 7 章美国生物製药第三方物流市场：服务类型细分分析

  • 美国生物製药第三方物流市场：2021 年和 2030 年市场份额分析
  • 交通
    • 空运
    • 海运
    • 地面交通
  • 仓库和仓储
  • 其他服务

第 8 章美国生物製药第三方物流市场：产品类型细分分析

  • 美国生物製药第三方物流市场：2021 年和 2030 年市场份额分析
  • 特殊药物
  • 通用的
  • 血浆衍生产品
  • 其他

第九章公司简介

  • 公司简介
    • FedEx
      • 公司简介
      • 财务业绩
      • 产品基准
    • DHL International GmbH
      • 公司简介
      • 财务业绩
      • 产品基准
    • SF Express
      • 公司简介
      • 财务业绩
      • 产品基准
    • United Parcel Service of America, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • AmerisourceBergen Corporation
      • 公司简介
      • 财务业绩
      • 产品基准
    • DB Schenker
      • 公司简介
      • 财务业绩
      • 产品基准
    • KUEHNE+NAGEL
      • 公司简介
      • 财务业绩
      • 产品基准
    • Kerry Logistics Network Limited
      • 公司简介
      • 财务业绩
      • 产品基准
    • Agility
      • 公司简介
      • 财务业绩
      • 产品基准
Product Code: GVR-4-68038-381-2

U.S. Biopharmaceutical Third-party Logistics Market Growth & Trends:

The U.S. biopharmaceutical third-party logistics market size is expected to reach USD 87.2 billion by 2030, expanding at a CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for novel biologics and the need to manage those is boosting the market growth. Besides, rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the growth.

The COVID-19 pandemic has had a major impact on global logistics to some extent due to diminished air freight capacity and reduced workforce at warehouses and airports. The decisions of local authorities to shut down the logistic infrastructure, enforce movement restrictions, or put in place additional requirements to suppress transmission of the virus have also impacted the logistic services. This has significantly hindered many supply operations.

The future seems lucrative for the biopharmaceutical third-party logistics industry in the U.S. with the retraction of government regulations related to transportation and shelter-in-place mandates. A sudden surge in the demand for cold chain logistics was observed during the pandemic. Growth in the manufacture and distribution of the COVID-19 vaccine is expected throughout 2021. For instance, in March 2021, FedEx Express started shipping COVID-19 vaccines for McKesson Corp. to centers all across the U.S. The company has already shipped millions of COVID-19 vaccines since mid-December 2020.

U.S. Biopharmaceutical Third-party Logistics Market Highlights:

  • Non-cold chain logistics held the largest market share of 80.2% owing to the sales of a large number of drugs that do not require any temperature control
  • The cold chain logistics segment is projected to witness the fastest CAGR of 10.1% over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
  • The increasing demand for the COVID-19 vaccine is a major contributor to the market growth. Furthermore, the rising trend of outsourcing logistics services is also fueling the growth
  • Warehousing and storage held the largest market share of 43.4% share due to the growing demand for storage
  • Specialty drugs dominated the market with the largest share of 39.2% in 2021 due to substantial growth in specialty pharma

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Supply Chain
    • 1.1.2 Services Type
    • 1.1.3 Product Type
    • 1.1.4 Regional Scope
    • 1.1.5 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.2 Volume Price Analysis (Model 2)
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective - 1
    • 1.10.2 Objective - 2
    • 1.10.3 Objective - 3
    • 1.10.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook

Chapter 3 Market Definition

    • 3.1.1 By Supply Chain
    • 3.1.2 By Services Type
    • 3.1.3 By Product type

Chapter 4 U.S. Biopharmaceutical Third-party Logistics Market: Variables, Trends, & Scope

  • 4.1 Market Segmentation and Scope
  • 4.2 Market Driver Analysis
    • 4.2.1 Technological advancements in logistics
    • 4.2.2 Growing applications of reverse logistics in the biopharmaceutical industry
    • 4.2.3 Rising demand for cold chain logistics
  • 4.3 Market Restraint Analysis
    • 4.3.1 Compliance Issues While Outsourcing
  • 4.4 Penetration & Growth Prospect Mapping
  • 4.5 Porter's Five Forces Analysis
  • 4.6 PESTEL Analysis
  • 4.7 Covid Impact and Reformation Analysis

Chapter 5 Qualitative Information for Hub Services, Copay, and Adherence

  • 5.1 Hub Services
  • 5.2 Copay
  • 5.3 Adherence

Chapter 6 U.S. Biopharmaceutical Third-party Logistics Market: Supply Chain Segment Analysis

  • 6.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 6.2 Cold Chain Logistics
    • 6.2.1 Cold Chain Logistics market, 2018 - 2030 (USD Billion)
  • 6.3 Non-cold Chain Logistics
    • 6.3.1 Non-cold Chain Logistics market, 2018 - 2030 (USD Billion)

Chapter 7 U.S. Biopharmaceutical Third-party Logistics Market: Services Type Segment Analysis

  • 7.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 7.2 Transportation
    • 7.2.1 Transportation market, 2018 - 2030 (USD Billion)
    • 7.2.2 Air freight
      • 7.2.2.1 Air freight market, 2018 - 2030 (USD Billion)
    • 7.2.3 Sea freight
      • 7.2.3.1 Sea freight market, 2018 - 2030 (USD Billion)
    • 7.2.4 Overland transportation
      • 7.2.4.1 Overland transportation market, 2018 - 2030 (USD Billion)
  • 7.3 Warehousing and Storage
    • 7.3.1 Warehousing and Storage market, 2018 - 2030 (USD Billion)
  • 7.4 Other Services
    • 7.4.1 Other Services market, 2018 - 2030 (USD Billion)

Chapter 8 U.S. Biopharmaceutical Third-party Logistics Market: Product Type Segment Analysis

  • 8.1 U.S. Biopharmaceutical Third-party Logistics Market: Market Share Analysis, 2021 & 2030
  • 8.2 Specialty Drugs
    • 8.2.1 Specialty Drugs market, 2018 - 2030 (USD Billion)
  • 8.3 Generics
    • 8.3.1 Generics market, 2018 - 2030 (USD Billion)
  • 8.4 Plasma-Derived Products
    • 8.4.1 Plasma Derived Products market, 2018 - 2030 (USD Billion)
  • 8.5 Others
    • 8.5.1 Others market, 2018 - 2030 (USD Billion)

Chapter 9 Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 FedEx
      • 9.1.1.1 Company overview
      • 9.1.1.2 Financial performance
      • 9.1.1.3 Product benchmarking
    • 9.1.2 DHL International GmbH
      • 9.1.2.1 Company overview
      • 9.1.2.2 Financial performance
      • 9.1.2.3 Product benchmarking
    • 9.1.3 SF Express
      • 9.1.3.1 Company overview
      • 9.1.3.2 Financial performance
      • 9.1.3.3 Product benchmarking
    • 9.1.4 United Parcel Service of America, Inc.
      • 9.1.4.1 Company overview
      • 9.1.4.2 Financial performance
      • 9.1.4.3 Product benchmarking
      • 9.1.4.4 Strategic initiatives
    • 9.1.5 AmerisourceBergen Corporation
      • 9.1.5.1 Company overview
      • 9.1.5.2 Financial performance
      • 9.1.5.3 Product benchmarking
    • 9.1.6 DB Schenker
      • 9.1.6.1 Company overview
      • 9.1.6.2 Financial performance
      • 9.1.6.3 Product benchmarking
    • 9.1.7 KUEHNE + NAGEL
      • 9.1.7.1 Company overview
      • 9.1.7.2 Financial performance
      • 9.1.7.3 Product benchmarking
    • 9.1.8 Kerry Logistics Network Limited
      • 9.1.8.1 Company overview
      • 9.1.8.2 Financial performance
      • 9.1.8.3 Product benchmarking
    • 9.1.9 Agility
      • 9.1.9.1 Company overview
      • 9.1.9.2 Financial performance
      • 9.1.9.3 Product benchmarking

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Biopharmaceutical Third-party Logistics Market, By Supply Chain, 2018 -2030 (USD Billion)
  • Table 4 U.S. Biopharmaceutical Third-party Logistics Market, By Service Type, 2018 -2030 (USD Billion)
  • Table 5 U.S. Biopharmaceutical Third-party Logistics Market, By Transportation, 2018 -2030 (USD Billion)
  • Table 6 U.S. Biopharmaceutical Third-party Logistics Market, By Product Type, 2018 -2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 U.S. Biopharmaceutical Third-party Logistics market snapshot (2020)
  • Fig. 11 U.S. Biopharmaceutical Third-party Logistics market segmentation
  • Fig. 12 Market driver relevance analysis (Current & future impact)
  • Fig. 13 Market restraint relevance analysis (Current & future impact)
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Reasons for non-adherence in the U.S.
  • Fig. 18 U.S. Biopharmaceutical Third-party Logistics market supply chain outlook: Segment dashboard
  • Fig. 19 U.S. Biopharmaceutical Third-party Logistics market: Supply chain movement analysis
  • Fig. 20 Cold chain logistics market, 2018 - 2030 (USD Billion)
  • Fig. 21 Non-cold chain logistics market, 2018 - 2030 (USD Billion)
  • Fig. 22 U.S. Biopharmaceutical Third-party Logistics market services type outlook: Segment dashboard
  • Fig. 23 U.S. Biopharmaceutical Third-party Logistics market: Services Type movement analysis
  • Fig. 24 Transportation market, 2018 - 2030 (USD Billion)
  • Fig. 25 Air freight market, 2018 - 2030 (USD Billion)
  • Fig. 26 Sea freight market, 2018 - 2030 (USD Billion)
  • Fig. 27 Overland transportation market, 2018 - 2030 (USD Billion)
  • Fig. 28 Warehousing and storage market, 2018 - 2030 (USD Billion)
  • Fig. 29 Other services market, 2018 - 2030 (USD Billion)
  • Fig. 30 U.S. Biopharmaceutical Third-party Logistics market product type outlook: Segment dashboard
  • Fig. 31 U.S. Biopharmaceutical Third-party Logistics market: Product type movement analysis
  • Fig. 32 Specialty drugs market, 2018 - 2030 (USD Billion)
  • Fig. 33 Generics market, 2018 - 2030 (USD Billion)
  • Fig. 34 Plasma-derived products market, 2018 - 2030 (USD Billion)
  • Fig. 35 Others market, 2018 - 2030 (USD Billion)